SLC7A11 and central nervous system cancer: The aberrant glutamate release by glioma cells is primarily mediated by the xCT glutamate/cystine antiporter [25,26,27,28,29,30,31], whose surface expression is regulated by interaction with the epidermal growth factor receptor (EGFR) [30].